The spike effect of acute respiratory syndrome coronavirus 2 and coronavirus disease 2019 vaccines on blood pressure

F Angeli, M Zappa, G Reboldi, G Gentile… - European Journal of …, 2023 - Elsevier
Among the various comorbidities potentially worsening the clinical outcome in patients
hospitalized for the acute respiratory syndrome coronavirus-2 (SARS-CoV-2), hypertension …

[HTML][HTML] Global burden of new-onset hypertension associated with severe acute respiratory syndrome coronavirus 2 infection

F Angeli, M Zappa, P Verdecchia - European journal of internal medicine, 2024 - Elsevier
Several reports documented a specific effect of the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) on blood pressure (BP), during and after the acute phase of …

Arterial Hypertension as a Risk Comorbidity Associated with COVID‐19 Pathology

A Kamyshnyi, I Krynytska, V Matskevych… - International journal …, 2020 - Wiley Online Library
Coronavirus disease 2019 (COVID‐19), caused by the novel coronavirus severe acute
respiratory syndrome‐coronavirus‐2 (SARS‐CoV‐2), is an ongoing global public health …

Influence of blood pressure control and application of renin‐angiotensin‐aldosterone system inhibitors on the outcomes in COVID‐19 patients with hypertension

R Chen, J Yang, X Gao, X Ding, Y Yang… - The Journal of …, 2020 - Wiley Online Library
Hypertension is proved to be associated with severity and mortality in coronavirus disease
2019 (COVID‐19). However, little is known about the effects of pre‐admission and/or in …

Hypertension, the renin–angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19: European Society of …

R Kreutz, EAEH Algharably, M Azizi… - Cardiovascular …, 2020 - academic.oup.com
Systemic arterial hypertension (referred to as hypertension herein) is a major risk factor of
mortality worldwide, and its importance is further emphasized in the context of the novel …

Hypertension artérielle et COVID-19

A Cinaud, E Sorbets, V Blachier, A Vallee… - La Presse Médicale …, 2021 - Elsevier
Key points Age and cardiovascular comorbidities, but not hypertension, are independent risk
factors of mortality and hospitalization in intensive care units in coronavirus 19 (COVID-19) …

Role of Hypertension on the Severity of COVID-19: A Review

M Peng, J He, Y Xue, X Yang, S Liu… - Journal of …, 2021 - journals.lww.com
The novel coronavirus disease (COVID-19) caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has rapidly evolved into a global pandemic. The …

[HTML][HTML] Effects of angiotensin II receptor blocker usage on viral load, antibody dynamics, and transcriptional characteristics among COVID-19 patients with …

F Baihuan, D Zhang, W Qi, YU Fei… - Journal of Zhejiang …, 2021 - ncbi.nlm.nih.gov
Epidemiological evidence suggests that patients with hypertension infected with severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are at increased risk of acute lung …

The influence of pre-existing hypertension on coronavirus disease 2019 patients

ZY Wei, R Qiao, J Chen, J Huang, H Wu… - Epidemiology & …, 2021 - cambridge.org
Hypertension represents one of the most common pre-existing conditions and comorbidities
in Coronavirus disease 2019 (COVID-19) patients. To explore whether hypertension serves …

[HTML][HTML] Hypertension and COVID-19: current evidence and perspectives

G Gallo, V Calvez, C Savoia - High Blood Pressure & Cardiovascular …, 2022 - Springer
Abstract Coronavirus disease 2019 (COVID-19) outbreak, caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), represents a real challenge for health …